PARP Inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference77 articles.
1. Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme
2. In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)
3. Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
4. Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA
5. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study;Scientific Reports;2023-07-24
2. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy;BMC Cancer;2023-07-21
3. Small cell lung cancer: Novel treatments beyond immunotherapy;Seminars in Cancer Biology;2022-11
4. Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression;Nuclear Medicine and Biology;2022-11
5. Current status and progress in using radiolabelled PARP-1 inhibitors for imaging PARP-1 expression in tumours;European Journal of Medicinal Chemistry;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3